ESPR
Esperion Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.18
+0.00%0
Insider buys (3m)
3
Insider sells (3m)
-$240.4K
Net value (3m)
+46.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | Koenig Sheldon L. · director, officer: President and CEO | Sale | 53,588 | $3.15 |
| Jun 18, 2026 | Halladay Benjamin · officer: Chief Financial Officer | Sale | 10,773 | $3.15 |
| Jun 18, 2026 | Looker Benjamin · officer: Chief Legal Officer | Sale | 11,824 | $3.15 |
| Jun 1, 2026 | Shepard Jay · director | A-Award | 79,873 | $0.00 |
| Jun 1, 2026 | THOMPSON JOHN CRAIG · director | A-Award | 79,873 | $0.00 |
| Jun 1, 2026 | Hoffman Robert E. · director | A-Award | 79,873 | $0.00 |
| Jun 1, 2026 | Fischer Seth H. Z. · director | A-Award | 79,873 | $0.00 |
| Jun 1, 2026 | CARROLL J MARTIN · director | A-Award | 79,873 | $0.00 |
| Mar 18, 2026 | Koenig Sheldon L. · director, officer: President and CEO | Sale | 25,578 | $2.72 |
| Mar 18, 2026 | Looker Benjamin · officer: Chief Legal Officer | Sale | 5,708 | $2.70 |
| Mar 18, 2026 | Halladay Benjamin · officer: Chief Financial Officer | Sale | 6,424 | $2.71 |
| Mar 16, 2026 | Koenig Sheldon L. · director, officer: President and CEO | A-Award | 723,760 | $0.00 |
| Mar 16, 2026 | Halladay Benjamin · officer: Chief Financial Officer | A-Award | 247,430 | $0.00 |
| Mar 16, 2026 | Looker Benjamin · officer: Chief Legal Officer | A-Award | 269,230 | $2.44 |
| Mar 16, 2026 | Looker Benjamin · officer: Chief Legal Officer | A-Award | 300,840 | $0.00 |
| Mar 16, 2026 | Koenig Sheldon L. · director, officer: President and CEO | A-Award | 647,460 | $2.44 |
| Mar 16, 2026 | Halladay Benjamin · officer: Chief Financial Officer | A-Award | 221,270 | $2.44 |
| Jan 21, 2026 | Looker Benjamin · officer: General Counsel | Sale | 1,689 | $2.88 |
| Dec 18, 2025 | Koenig Sheldon L. · director, officer: President and CEO | Sale | 48,244 | $3.67 |
| Dec 18, 2025 | Looker Benjamin · officer: General Counsel | Sale | 6,517 | $3.67 |
| Dec 18, 2025 | Halladay Benjamin · officer: Chief Financial Officer | Sale | 7,337 | $3.67 |
| Dec 8, 2025 | Harlow John B. Jr. · officer: Chief Commercial Officer | A-Award | 380,000 | $3.79 |
| Dec 8, 2025 | Harlow John B. Jr. · officer: Chief Commercial Officer | A-Award | 424,536 | $0.00 |
| Sep 18, 2025 | Halladay Benjamin · officer: Chief Financial Officer | Sale | 7,046 | $2.81 |
| Sep 18, 2025 | Looker Benjamin · officer: General Counsel | Sale | 6,267 | $2.80 |
| Sep 18, 2025 | Koenig Sheldon L. · director, officer: President and CEO | Sale | 28,427 | $2.79 |
| Jul 18, 2025 | Halladay Benjamin · officer: Chief Financial Officer | Sale | 11 | $1.11 |
| Jul 18, 2025 | Looker Benjamin · officer: General Counsel | Sale | 1,304 | $1.13 |
| Jul 2, 2025 | THOMPSON JOHN CRAIG · director | A-Award | 40,000 | $1.00 |
| Jun 18, 2025 | Koenig Sheldon L. · director, officer: President and CEO | Sale | 30,474 | $1.11 |
Institutional positioning
13F filings over the trailing two quarters
New 106Increased 113Reduced 117Sold out 78
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GLAZER CAPITAL, LLC | New Position | 22,416,339 | Aug 17, 2026 |
| BlackRock, Inc. | Increased | 22,128,021 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 17,852,427 | May 13, 2026 |
| WASATCH ADVISORS LP | Increased | 15,768,897 | Apr 21, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 11,427,437 | Aug 13, 2026 |
| TWO SEAS CAPITAL LP | Reduced | 11,394,833 | May 15, 2026 |
| Trium Capital LLP | New Position | 11,158,150 | Jul 16, 2026 |
| ORBIMED ADVISORS LLC | Increased | 10,570,300 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 10,433,760 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 10,380,646 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 9,458,779 | May 15, 2026 |
| STATE STREET CORP | Increased | 7,276,249 | Aug 7, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 7,126,739 | Aug 14, 2026 |
| MARSHALL WACE, LLP | Increased | 7,075,083 | May 15, 2026 |
| STATE STREET CORP | Increased | 7,055,794 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 18, 2026